Oxacilina

Bactocill

10GM BASE/VIAL, 1GM BASE/VIAL, 2GM BASE/VIAL injectableVerenigde StatenNiet in de handelToegelaten op 26 mrt 1982

In andere landen

Dezelfde werkzame stoffen in andere registers, met hetzelfde merk eerst.

OxcivaItalië · Polvere per soluzione iniettabile/per infusione · Avas Pharmaceuticals SRLZelfde vorm
PenstaphoItalië · Polvere e solvente per soluzione iniettabile · Laboratoires DelbertZelfde vorm
OXACILINA ATB 1000 mgRoemenië · 1000mg · pulb. pt. sol. inj./perf. · Antibiotice SAZelfde vorm
OXACILINA ATB 1000mgRoemenië · 1000mg · pulb. pt. sol. inj./perf. · Antibiotice SAZelfde vorm
OXACILINA ATB 1gRoemenië · 1g · pulb. pt. sol. inj. / perf. · Antibiotice SAZelfde vorm
OxacililBrazilië · Newcom Farmaceutica Ltda.Zelfde stof
Oxacilina SódicaBrazilië · Eugia Pharma Industria Farmaceutica LtdaZelfde stof

Verpakking	Code	Status
OXACILLIN SODIUM EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA061334-009	Discontinued
OXACILLIN SODIUM EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA061334-007	Discontinued
OXACILLIN SODIUM EQ 4GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA061334-008	Discontinued
OXACILLIN SODIUM EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA061334-006	Discontinued
OXACILLIN SODIUM EQ 10GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA061334-010	Discontinued
OXACILLIN SODIUM EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA062736-001	Discontinued
OXACILLIN SODIUM EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ANDA062736-002	Discontinued